Le Lézard
Classified in: Health
Subject: FEA

Galen College of Nursing ADN Program At Louisville And Hazard Campuses Granted ACEN Continuing Accreditation


LOUISVILLE, Ky., May 19, 2021 /PRNewswire/ -- Galen College of Nursing is happy to announce the Board of Commissioners on the Accreditation Commission for Education in Nursing (ACEN) has granted Continuing Accreditation to Galen's Associate Degree in Nursing (ADN) program at the Louisville and Hazard campuses. ACEN has been acknowledged as the leading authority for nursing education accreditation. Continuing accreditation is granted when the ACEN Board of Commissioners determines that a nursing program complies with all Accreditation Standards.

Louisville and Hazard are the first to successfully go through the ACEN continuing accreditation process - a significant moment in Galen College's history. The accreditation status extends through Galen's next site visit, which will occur in the Fall of 2028.

"I am so honored and proud of this accomplishment", said Academic Dean at the Louisville campus, Lisa Peak, MSN, RN, CNE. "The continued accreditation reflects the dedication of the incredible faculty and staff and commitment to excellence in nursing education. I am truly blessed to be part of such an incredible organization".

Galen's 2-Year ADN program is designed to help individuals start their journey to becoming registered nurses (RN). The program features hands-on learning with a strong clinical-based curriculum that prepares students to sit for the NCLEX® licensure exam. Virtual admissions appointments can be scheduled by calling (877) 223-7040 or go online to galencollege.edu.

View the public information disclosed by the ACEN regarding this program at http://www.acenursing.com/accreditedprograms/programsearch.htm or contact ACEN at
3390 Peachtree Road NE, Suite 1400 Atlanta, GA 30326; (404) 975-5000

About Galen College of Nursing
Founded over 30 years ago, Galen College of Nursing is one of the largest private nursing schools in the United States. With a focus solely on nursing education, Galen offers master's, baccalaureate, associate, and practical/vocational nursing programs, to over 8,000 students on its campuses in Louisville and Hazard, KY.; San Antonio, TX; Tampa Bay and Miami, FL.; Cincinnati, OH; and online. Galen is accredited by the Southern Association of Colleges and Schools Commission on Colleges (SACSCOC). Programmatic accreditation status for Galen's multiple programs and nationwide campuses can be found at https://www.galencollege.edu/about-galen/accreditation. For more information about Galen College of Nursing, visit galencollege.edu.

Contact:
Andy Stillwagon, Brand Communications Director
(502) 387-7476 (cell)
[email protected]

SOURCE Galen College of Nursing


These press releases may also interest you

at 08:00
Optimi Health Receives Export Permit from Health Canada to Ship MDMA To Tel Aviv University's Institute for Psychedelic Research
Optimi Health Corp.  (FRA: 8BN), a leading Health Canada licensed GMP psychedelics pharmaceutical manufacturer, specializing in controlled substances such as botanical psilocybin and MDMA, is pleased to report a significant update to its...

at 07:55
Syra Health Announces First Quarter 2024 Financial Results, Led By Strong Revenue Growth of 47%.
Syra Health Corp. , ("Syra Health" or the "Company") a healthcare technology company with a mission to improve healthcare by providing innovative services and technology solutions, announced today its financial results for the first quarter...

at 07:49
Legacy Sponge-on-a-String Esophageal Cell Collection Device Subject of Class II FDA Recall
Lucid Diagnostics Inc.  ("Lucid" or the "Company") a commercial-stage, cancer prevention medical diagnostics company, and majority-owned subsidiary of PAVmed Inc. ("PAVmed"), announced that the legacy EsophaCap sponge-on-a-string...

at 07:35
Dr. Reginald Seeto Appointed as CEO and President, to Lead Scipher Medicine's Next Phase of Growth
Scipher Medicine, an AI-enabled precision immunology company, today announced the appointment of Reginald Seeto, MBBS*, as Chief Executive Officer and President. Scipher developed SpectraTM, a proprietary AI platform that has been used to build both...

at 07:35
Merrimack Pharmaceuticals, Inc. Announces Anticipated Final Cash Dividend Amount of Initial Liquidating Distribution, Subject to Receipt of Stockholder Approval of Plan of Dissolution
Merrimack Pharmaceuticals, Inc. ("Merrimack" or the "Company") today announced that the Board of Directors intends to declare a liquidating cash dividend in the amount of $15.10 per share, if stockholder approval of the Plan of Dissolution is...

at 07:35
Nvelop Therapeutics to Share the First Preclinical Data from its Novel, Humanized Particle Platform for In Vivo Delivery of Genetic Cargoes at the ASGCT Annual Meeting
Nvelop Therapeutics, a biotechnology company engineering programmable, non-viral vehicles for the in vivo delivery of therapeutic cargo, today announced the presentation of new preclinical data from its DLVR-M platform at the 27th annual meeting of...

More news about Health...


News published on and distributed by: